User: Guest

PEDIATRIC DRUGS AND VACCINES

Global Market Trajectory & Analytics

MCP-6503

VALIDATED EXECUTIVE ENGAGEMENTS

POOL + OUTREACH

11366
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1364
Interactions with Platform & by Email

PARTICIPANTS

341
Unique # Participated

VALIDATIONS

153
Responses Validated*
* Login to view program details and full enterprise executive list.

DATE

JULY 2020

TABLES

120

PAGES

240

EDITION

15

PRICE

USD $5600


GLOBAL EXECUTIVE SURVEY

Impact of Pandemic & Economic Slowdown

Monitor Market Dynamics!

Early March 2020, we reached out to senior enterprise executives who are driving strategy, business development, marketing, sales, product management, technology and operations at competitive firms worldwide. Our ongoing survey is focused on how this will this affect their business ecosystems. We invite you to participate in our survey and add to collective perspectives. Market movements are tracked for 2020, 2021 and broadly for the period of 2022 through 2025. Critical changes are monitored dynamically for the rest of this year. Updated analytics will reflect new and evolving market realities. Our first update scheduled for May 2020 and another in the Fall. Clients receive complimentary updates during 2020. If your company is a recent client for this project, we may have already reached out to your colleagues to participate in our program. If you're an active player in the space but hasn't yet subscribed to our project, we invite you to participate and share your perspectives. Please sign-up here.

Amid the COVID-19 crisis, the global market for Pediatric Drugs and Vaccines estimated at US$100.1 Billion in the year 2020, is projected to reach a revised size of US$148.8 Billion by 2027, growing at a CAGR of 5.8% over the analysis period 2020-2027. Antibiotics, one of the segments analyzed in the report, is projected to record a 5.9% CAGR and reach US$36.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Vaccines segment is readjusted to a revised 6.8% CAGR for the next 7-year period.
The Pediatric Drugs and Vaccines market in the U.S. is estimated at US$27.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$31.4 Billion by the year 2027 trailing a CAGR of 8.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 5.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.
In the global Allergy & Respiratory segment, USA, Canada, Japan, China and Europe will drive the 3.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$14.1 Billion in the year 2020 will reach a projected size of US$18.4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$20.1 Billion by the year 2027, while Latin America will expand at a 5.3% CAGR through the analysis period. We bring years of research experience to this 15th edition of our report. The 240-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Abbott Laboratories; Allergan Inc.; Amgen Inc.; AstraZeneca Plc; Boehringer Ingelheim GmbH; Bristol-Myers Squibb Company; Eli Lilly and Company; F. Hoffmann-La Roche Ltd; Genentech Inc.; GlaxoSmithKline Plc; Janssen Biologics B.V; Merck & Co. Inc.; Novartis AG; Novo Nordisk A/S; Pfizer Inc.; Sanofi; Shionogi Inc.; Shire Pharmaceuticals Group Plc
» Therapeutic Class (Antibiotics, Vaccines, Allergy & Respiratory, CNS, Hormones, Other Therapeutic Classes)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

ACTIVE CLIENT

INACTIVE CLIENT

ACTIVE PANELIST

INACTIVE PANELIST

OPT-INS

FEATURED COMPANIES

Registration is required to access our data stacks.

WORLD BRANDS

Registration is required to access our data stacks.

EXECUTIVES ENGAGED

Registration is required to access our data stacks.

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

  
05
1. MARKET OVERVIEW
Pediatrics: A Highly Underserved and Undervalued Group
Recent Market Activity
Pediatric Drugs Market - An Abode of Opportunities
The United States: Largest Market for Pediatric Drugs and Vaccines
Developing Markets to Witness Faster Growth
Antibiotics: Largest Selling Drug Classes
Pediatric Vaccines Market - On High Growth Trajectory
Supply and Demand Dynamics of the Global Vaccine Market
UNICEF Addresses BCG Vaccine Supply Shortage
Access to Vaccines Index: Aiding Increased Access to Vaccines
Recent Advancements/Achievements in the Pediatric Vaccines Space
Global Competitor Market Shares
Pediatric Drugs and Vaccines Competitor Market Share Scenario Worldwide (in %): 2020 & 2029
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
Abbott Laboratories (USA)
Allergan, Inc. (USA)
Amgen, Inc. (USA)
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals Ltd (Switzerland) (A Janssen Pharmaceutical Company)
Merck & Co., Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Shire Pharmaceuticals Group Plc. (UK)
3. MARKET TRENDS & DRIVERS
Pediatric Exclusivity Drives Manufacturers Interest
Pediatric Exclusitivity Granted to Branded Drugs
New Product Approvals and Pipeline - A Key Growth Propeller
Recent Pediatric Drug Approvals: 2015-2017
Pediatric Drug Approvals: 2011-2014
Phase III Completed Pediatric Drugs: 2015-2017 (As of July 2017)
Ongoing Phase III Pediatric Drugs Clinical Trials: 2015-2017 (As of July 2017)
Potential for Pediatric Drugs Against Obesity-related Conditions
List of Pediatric Drugs for Congestive Heart Failure Treatment
Recent Findings to Help Save Childrens Lives
Challenges of Pediatric Drug Development: Formulation Problems and Ethical Constraints of Clinical Trials
Financial Enticement for Drug Makers to Conduct Dedicated Pediatric Trials
Modeling & Simulation - A Powerful Tool for Pediatric Clinical Study Sponsors
Pharmacometrics Approaches Gain Traction Among US and EU Researchers
Challenges Associated with Adoption of Pharmacometric Approach
Guidelines for Conducting Ethically Correct Clinical Trials
Pediatric Drug Market - Is Off-label Prescription Justified?
Indian Drug Manufacturers Develop Pneumococcal Conjugate Vaccine
High Vaccination Costs: A Major Hindrance for Pneumonia Vaccination
Vaccine Refusal by Parents - A Growing Trend in the US Market
Orphan Drugs for Pediatric Use Gain Popularity
List of FDA Approved Orphan Drugs: 2015-2016
List of FDA Designated Orphan Drugs: 2015-2017
Pediatric Review Vouchers Foster Innovation in Rare Pediatric Drugs
Need for Higher Focus on Fixed-Dose Combination for Pediatric HIV Infections
Approved Pediatric Antiretroviral Drugs for HIV Treatment
Highly Fragmented Growth Hormone Market
4. GLOBAL MARKET PERSPECTIVE
Pediatric Drugs and Vaccines Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
Pediatric Drugs and Vaccines Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
Pediatric Drugs and Vaccines Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
Antibiotics (Therapeutic Class) World Market by Region/Country in US$ Million: 2018 to 2025
Antibiotics (Therapeutic Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
Antibiotics (Therapeutic Class) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Vaccines (Therapeutic Class) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
Vaccines (Therapeutic Class) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
Vaccines (Therapeutic Class) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
Allergy & Respiratory (Therapeutic Class) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
Allergy & Respiratory (Therapeutic Class) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
Allergy & Respiratory (Therapeutic Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
CNS (Therapeutic Class) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
CNS (Therapeutic Class) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
CNS (Therapeutic Class) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
Hormones (Therapeutic Class) World Market by Region/Country in US$ Million: 2018 to 2025
Hormones (Therapeutic Class) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
Hormones (Therapeutic Class) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
Other Therapeutic Classes (Therapeutic Class) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025
Other Therapeutic Classes (Therapeutic Class) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017
Other Therapeutic Classes (Therapeutic Class) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025
GEOGRAPHIC MARKET ANALYSIS
United States
Market Facts & Figures
US Pediatric Drugs and Vaccines Market Share (in %) by Company: 2020 & 2025
United States Pediatric Drugs and Vaccines Market Estimates and Projections in US$ Million by Therapeutic Class: 2018 to 2025
Pediatric Drugs and Vaccines Market in the United States by Therapeutic Class: A Historic Review in US$ Million for 2009-2017
United States Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
Canada
Canadian Pediatric Drugs and Vaccines Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018 to 2025
Canadian Pediatric Drugs and Vaccines Historic Market Review by Therapeutic Class in US$ Million: 2009-2017
Pediatric Drugs and Vaccines Market in Canada: Percentage Share Breakdown of Sales by Therapeutic Class for 2009, 2019, and 2025
Japan
Japanese Market for Pediatric Drugs and Vaccines: Annual Sales Estimates and Projections in US$ Million by Therapeutic Class for the Period 2018-2025
Pediatric Drugs and Vaccines Market in Japan: Historic Sales Analysis in US$ Million by Therapeutic Class for the Period 2009-2017
Japanese Pediatric Drugs and Vaccines Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
China
Chinese Pediatric Drugs and Vaccines Market Growth Prospects in US$ Million by Therapeutic Class for the Period 2018-2025
Pediatric Drugs and Vaccines Historic Market Analysis in China in US$ Million by Therapeutic Class: 2009-2017
Chinese Pediatric Drugs and Vaccines Market by Therapeutic Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
Europe
Market Facts & Figures
European Pediatric Drugs and Vaccines Market: Competitor Market Share Scenario (in %) for 2020 & 2025
European Pediatric Drugs and Vaccines Market Demand Scenario in US$ Million by Region/Country: 2018-2025
Pediatric Drugs and Vaccines Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
European Pediatric Drugs and Vaccines Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
European Pediatric Drugs and Vaccines Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018-2025
Pediatric Drugs and Vaccines Market in Europe in US$ Million by Therapeutic Class: A Historic Review for the Period 2009-2017
European Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
France
Pediatric Drugs and Vaccines Market in France by Therapeutic Class: Estimates and Projections in US$ Million for the Period 2018-2025
French Pediatric Drugs and Vaccines Historic Market Scenario in US$ Million by Therapeutic Class: 2009-2017
French Pediatric Drugs and Vaccines Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
Germany
Pediatric Drugs and Vaccines Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Class for the Period 2018-2025
German Pediatric Drugs and Vaccines Historic Market Analysis in US$ Million by Therapeutic Class: 2009-2017
German Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
Italy
Italian Pediatric Drugs and Vaccines Market Growth Prospects in US$ Million by Therapeutic Class for the Period 2018-2025
Pediatric Drugs and Vaccines Historic Market Analysis in Italy in US$ Million by Therapeutic Class: 2009-2017
Italian Pediatric Drugs and Vaccines Market by Therapeutic Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
United Kingdom
United Kingdom Market for Pediatric Drugs and Vaccines: Annual Sales Estimates and Projections in US$ Million by Therapeutic Class for the Period 2018-2025
Pediatric Drugs and Vaccines Market in the United Kingdom: Historic Sales Analysis in US$ Million by Therapeutic Class for the Period 2009-2017
United Kingdom Pediatric Drugs and Vaccines Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
Spain
Spanish Pediatric Drugs and Vaccines Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018 to 2025
Spanish Pediatric Drugs and Vaccines Historic Market Review by Therapeutic Class in US$ Million: 2009-2017
Pediatric Drugs and Vaccines Market in Spain: Percentage Share Breakdown of Sales by Therapeutic Class for 2009, 2019, and 2025
Russia
Russian Pediatric Drugs and Vaccines Market Estimates and Projections in US$ Million by Therapeutic Class: 2018 to 2025
Pediatric Drugs and Vaccines Market in Russia by Therapeutic Class: A Historic Review in US$ Million for 2009-2017
Russian Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
Rest of Europe
Rest of Europe Pediatric Drugs and Vaccines Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018-2025
Pediatric Drugs and Vaccines Market in Rest of Europe in US$ Million by Therapeutic Class: A Historic Review for the Period 2009-2017
Rest of Europe Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
Asia-Pacific
Asia-Pacific Pediatric Drugs and Vaccines Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
Pediatric Drugs and Vaccines Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
Asia-Pacific Pediatric Drugs and Vaccines Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
Pediatric Drugs and Vaccines Market in Asia-Pacific by Therapeutic Class: Estimates and Projections in US$ Million for the Period 2018-2025
Asia-Pacific Pediatric Drugs and Vaccines Historic Market Scenario in US$ Million by Therapeutic Class: 2009-2017
Asia-Pacific Pediatric Drugs and Vaccines Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
Australia
Pediatric Drugs and Vaccines Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Class for the Period 2018-2025
Australian Pediatric Drugs and Vaccines Historic Market Analysis in US$ Million by Therapeutic Class: 2009-2017
Australian Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
India
Indian Pediatric Drugs and Vaccines Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018 to 2025
Indian Pediatric Drugs and Vaccines Historic Market Review by Therapeutic Class in US$ Million: 2009-2017
Pediatric Drugs and Vaccines Market in India: Percentage Share Breakdown of Sales by Therapeutic Class for 2009, 2019, and 2025
South Korea
Pediatric Drugs and Vaccines Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Class for the Period 2018-2025
South Korean Pediatric Drugs and Vaccines Historic Market Analysis in US$ Million by Therapeutic Class: 2009-2017
Pediatric Drugs and Vaccines Market Share Distribution in South Korea by Therapeutic Class: 2009 VS 2019 VS 2025
Rest of Asia-Pacific
Rest of Asia-Pacific Market for Pediatric Drugs and Vaccines: Annual Sales Estimates and Projections in US$ Million by Therapeutic Class for the Period 2018-2025
Pediatric Drugs and Vaccines Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Therapeutic Class for the Period 2009-2017
Rest of Asia-Pacific Pediatric Drugs and Vaccines Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
Latin America
Latin American Pediatric Drugs and Vaccines Market Trends by Region/Country in US$ Million: 2018-2025
Pediatric Drugs and Vaccines Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
Latin American Pediatric Drugs and Vaccines Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
Latin American Pediatric Drugs and Vaccines Market Growth Prospects in US$ Million by Therapeutic Class for the Period 2018-2025
Pediatric Drugs and Vaccines Historic Market Analysis in Latin America in US$ Million by Therapeutic Class: 2009-2017
Latin American Pediatric Drugs and Vaccines Market by Therapeutic Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
Argentina
Argentinean Pediatric Drugs and Vaccines Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018-2025
Pediatric Drugs and Vaccines Market in Argentina in US$ Million by Therapeutic Class: A Historic Review for the Period 2009-2017
Argentinean Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
Brazil
Pediatric Drugs and Vaccines Market in Brazil by Therapeutic Class: Estimates and Projections in US$ Million for the Period 2018-2025
Brazilian Pediatric Drugs and Vaccines Historic Market Scenario in US$ Million by Therapeutic Class: 2009-2017
Brazilian Pediatric Drugs and Vaccines Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
Mexico
Pediatric Drugs and Vaccines Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Class for the Period 2018-2025
Mexican Pediatric Drugs and Vaccines Historic Market Analysis in US$ Million by Therapeutic Class: 2009-2017
Mexican Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
Rest of Latin America
Rest of Latin America Pediatric Drugs and Vaccines Market Estimates and Projections in US$ Million by Therapeutic Class: 2018 to 2025
Pediatric Drugs and Vaccines Market in Rest of Latin America by Therapeutic Class: A Historic Review in US$ Million for 2009-2017
Rest of Latin America Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
Middle East
The Middle East Pediatric Drugs and Vaccines Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
Pediatric Drugs and Vaccines Market in the Middle East by Region/Country in US$ Million: 2009-2017
The Middle East Pediatric Drugs and Vaccines Market Share Breakdown by Region/Country: 2009, 2019, and 2025
The Middle East Pediatric Drugs and Vaccines Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018 to 2025
The Middle East Pediatric Drugs and Vaccines Historic Market by Therapeutic Class in US$ Million: 2009-2017
Pediatric Drugs and Vaccines Market in the Middle East: Percentage Share Breakdown of Sales by Therapeutic Class for 2009, 2019, and 2025
Iran
Iranian Market for Pediatric Drugs and Vaccines: Annual Sales Estimates and Projections in US$ Million by Therapeutic Class for the Period 2018-2025
Pediatric Drugs and Vaccines Market in Iran: Historic Sales Analysis in US$ Million by Therapeutic Class for the Period 2009-2017
Iranian Pediatric Drugs and Vaccines Market Share Analysis by Therapeutic Class: 2009 VS 2019 VS 2025
Israel
Israeli Pediatric Drugs and Vaccines Market Estimates and Forecasts in US$ Million by Therapeutic Class: 2018-2025
Pediatric Drugs and Vaccines Market in Israel in US$ Million by Therapeutic Class: A Historic Review for the Period 2009-2017
Israeli Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
Saudi Arabia
Saudi Arabian Pediatric Drugs and Vaccines Market Growth Prospects in US$ Million by Therapeutic Class for the Period 2018-2025
Pediatric Drugs and Vaccines Historic Market Analysis in Saudi Arabia in US$ Million by Therapeutic Class: 2009-2017
Saudi Arabian Pediatric Drugs and Vaccines Market by Therapeutic Class: Percentage Breakdown of Sales for 2009, 2019, and 2025
United Arab Emirates
Pediatric Drugs and Vaccines Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Class for the Period 2018-2025
United Arab Emirates Pediatric Drugs and Vaccines Historic Market Analysis in US$ Million by Therapeutic Class: 2009-2017
Pediatric Drugs and Vaccines Market Share Distribution in United Arab Emirates by Therapeutic Class: 2009 VS 2019 VS 2025
Rest of Middle East
Pediatric Drugs and Vaccines Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Therapeutic Class for the Period 2018-2025
Rest of Middle East Pediatric Drugs and Vaccines Historic Market Analysis in US$ Million by Therapeutic Class: 2009-2017
Rest of Middle East Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
Africa
African Pediatric Drugs and Vaccines Market Estimates and Projections in US$ Million by Therapeutic Class: 2018 to 2025
Pediatric Drugs and Vaccines Market in Africa by Therapeutic Class: A Historic Review in US$ Million for 2009-2017
African Pediatric Drugs and Vaccines Market Share Breakdown by Therapeutic Class: 2009 VS 2019 VS 2025
Total Companies Profiled : 93

Click here to request a full table of contents and more details on this project.

INSIDER ACCESS TO

 METHODOLOGY  QUESTIONNAIRE  INFLUENCER NETWORK

Registration is required to access our data stacks.

RESEARCH PANEL

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.

  • Complimentary previews of full stack research data for participated
  • Insider access to research programs including engagements and stats from other panelists
  • Unlimited research credits of $1000 per participated project
  • Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
  • Interact with other panelists via our MarketGlassTM Data Exchange Platform*
  • BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*

* Complete details will be shared with panelists upon formal acceptance.

 GLOBAL EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com


Sales queries: Sales@StrategyR.com
Research queries: Info411@StrategyR.com